AstraZeneca Pharma India Ltd Reports Q3 2025 Financial Results with 542.2 Million Profit

AstraZeneca Pharma India Ltd, a leading pharmaceutical company, announced its financial results for the quarter ended September 30, 2025. The company reported a profit of 542.2 million, a 7.6% increase from the same period last year. The revenue from operations stood at 55909 million, while the total income was 56526 million. The total expenses were 48715 million, resulting in a profit before exceptional items and tax of 7811 million. The tax expense was 186.0 million, leading to a profit after tax of 542.2 million. The earnings per equity share of Rs 2/- each (basic and diluted) were 21.69. The company has classified certain assets as 'Assets classified as held for sale' due to the closure of its manufacturing site in Bangalore.